Successful intraprocedural anticoagulation with bivalirudin during pulmonary vein isolation in a patient with known heparin‐induced thrombocytopenia type II. Issue 2 (19th November 2015)

• Record Type: Journal Article
• Authors: Bellmann, Barbara; Nagel, Patrick; Muntean, Bogdan G.
• Is Part Of: Journal of arrhythmia. Volume 32:Issue 2(2016)
• Page Start: 154
• Page End: 155
• Publication Date: 2015-11-19
• Subjects: Pulmonary vein isolation -- Atrial fibrillation -- Heparin induced thrombocytopenia type II -- Bivalirudin -- Activated clotting time; Arrhythmia -- Periodicals; Cardiac pacing -- Periodicals; Arrhythmias, Cardiac; Arrhythmia; Cardiac pacing; Periodicals; Electronic journals; Periodicals; 616.128
• DOI: 10.1016/j.joa.2015.10.004
• Languages: English
• ISSNs: 1880-4276

Abstract

Abstract: We report the case of a 56‐year‐old female who presented with symptomatic paroxysmal atrial fibrillation. Anamnestic heparin‐induced thrombocytopenia (HIT) type II was suspected, and a rapid diagnostic test showed antibodies against platelet factor 4. The heparin‐induced platelet activation‐assay was negative. Radiofrequency pulmonary vein isolation with intraprocedural anticoagulation using bivalirudin was ultimately performed. Dosing was controlled by monitoring the activated clotting time. Post‐procedural blood tests were normal. There were no thromboembolic or bleeding events. Bivalirudin is a therapeutic option for anticoagulation during pulmonary vein isolation procedures in patients with a history of HIT type II.